Symbols / AMPE
AMPE Chart
About
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 307.28K |
| Enterprise Value | -3.36M | Income | -8.63M | Sales | — |
| Book/sh | 4.03 | Cash/sh | 3.63 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6 | IPO | — |
| P/E | — | Forward P/E | -3.01 | PEG | — |
| P/S | — | P/B | 0.07 | P/C | — |
| EV/EBITDA | 0.36 | EV/Sales | — | Quick Ratio | 2.12 |
| Current Ratio | 2.41 | Debt/Eq | 13.42 | LT Debt/Eq | — |
| EPS (ttm) | -10.66 | EPS next Y | -0.09 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2022-08-09 17:00 | ROA | -61.57% |
| ROE | -113.96% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.14M |
| Shs Float | 1.12M | Short Float | 2.94% | Short Ratio | 0.31 |
| Short Interest | — | 52W High | 0.28 | 52W Low | 0.00 |
| Beta | 6.62 | Avg Volume | 1.45K | Volume | 334.00 |
| Target Price | — | Recom | None | Prev Close | $0.15 |
| Price | $0.27 | Change | 79.65% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.27
Latest analyst target
3. DCF / Fair value
$-85.16
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.27
Low
—
High
—
Mean
—
- Ampio Announces Voluntary Delisting and SEC Deregistration - PR Newswire Mon, 25 Mar 2024 07
- AMPE Stock Price and Chart — OTC:AMPE - TradingView Sun, 09 Oct 2022 05
- Ampio Pharmaceuticals to delist from NYSE American - Investing.com Mon, 25 Mar 2024 07
- Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis $AMPE - MarketBeat Wed, 14 Oct 2015 22
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - Nasdaq Fri, 01 Dec 2023 08
- 6 Penny Stocks With 1,000% Upside Potential - Yahoo Finance Sun, 24 Jul 2022 07
- Cosmic Destroyer's Collectibles in Shorewood sells rare toys, figures and cards - Milwaukee Journal Sentinel Fri, 17 Dec 2021 08
- 7 Cheap Stocks Under $1 That Deserve A Second Look - Nasdaq hu, 15 Oct 2020 07
- Downgrade attacks enabled by newly discovered Wi-Fi flaw - SC Media Fri, 17 May 2024 07
- Will Merck (MRK) Stock Price Continue Bullishness Ahead Q2 2023? - The Coin Republic Sat, 29 Jul 2023 07
- Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC) - Defense World Wed, 28 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -9.34M | -23.16M | -22.97M |
| TotalUnusualItems | -56.00K | 3.83M | 3.49M |
| TotalUnusualItemsExcludingGoodwill | -56.00K | 3.83M | 3.49M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.63M | -16.34M | -17.07M |
| ReconciledDepreciation | 122.00K | 1.05M | 1.09M |
| EBITDA | -9.40M | -19.33M | -19.48M |
| EBIT | -9.52M | -20.38M | -20.57M |
| NetInterestIncome | 348.00K | 220.00K | 4.00K |
| InterestIncome | 348.00K | 220.00K | 4.00K |
| NormalizedIncome | -8.58M | -20.16M | -20.57M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.63M | -16.34M | -17.07M |
| TotalExpenses | 9.52M | 20.38M | 20.57M |
| DilutedAverageShares | 753.62K | 683.21K | |
| BasicAverageShares | 753.62K | 664.33K | |
| DilutedEPS | -29.32 | -30.00 | |
| BasicEPS | -21.68 | -27.00 | |
| DilutedNIAvailtoComStockholders | -8.63M | -22.10M | -17.07M |
| AverageDilutionEarnings | 0.00 | -5.76M | |
| NetIncomeCommonStockholders | -8.63M | -16.34M | -17.07M |
| NetIncome | -8.63M | -16.34M | -17.07M |
| NetIncomeIncludingNoncontrollingInterests | -8.63M | -16.34M | -17.07M |
| NetIncomeContinuousOperations | -8.63M | -16.34M | -17.07M |
| PretaxIncome | -8.63M | -16.34M | -17.07M |
| OtherIncomeExpense | 538.00K | 3.83M | 3.49M |
| OtherNonOperatingIncomeExpenses | 594.00K | ||
| SpecialIncomeCharges | -56.00K | -1.94M | 0.00 |
| GainOnSaleOfPPE | -56.00K | 0.00 | 0.00 |
| ImpairmentOfCapitalAssets | 0.00 | 1.94M | 0.00 |
| GainOnSaleOfSecurity | 5.76M | 3.49M | |
| NetNonOperatingInterestIncomeExpense | 348.00K | 220.00K | 4.00K |
| InterestIncomeNonOperating | 348.00K | 220.00K | 4.00K |
| OperatingIncome | -9.52M | -20.38M | -20.57M |
| OperatingExpense | 9.52M | 20.38M | 20.57M |
| DepreciationAmortizationDepletionIncomeStatement | 24.00K | ||
| DepreciationAndAmortizationInIncomeStatement | 24.00K | ||
| DepreciationIncomeStatement | 24.00K | ||
| ResearchAndDevelopment | 2.44M | 8.92M | 11.90M |
| SellingGeneralAndAdministration | 7.08M | 11.47M | 8.67M |
| GeneralAndAdministrativeExpense | 7.08M | 11.47M | 8.67M |
| OtherGandA | 4.59M | 7.73M | 3.24M |
| InsuranceAndClaims | 964.00K | 1.12M | 1.19M |
| SalariesAndWages | 1.52M | 2.61M | 4.25M |
| TotalRevenue | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 833.43K | 755.14K | 11.37M |
| ShareIssued | 833.43K | 755.14K | 11.37M |
| TotalDebt | 274.00K | 614.00K | 925.00K |
| TangibleBookValue | 3.36M | 11.79M | 27.28M |
| InvestedCapital | 3.36M | 11.79M | 27.28M |
| WorkingCapital | 3.36M | 12.14M | 30.51M |
| NetTangibleAssets | 3.36M | 11.79M | 27.28M |
| CapitalLeaseObligations | 274.00K | 614.00K | 925.00K |
| CommonStockEquity | 3.36M | 11.79M | 27.28M |
| TotalCapitalization | 3.36M | 11.79M | 27.28M |
| TotalEquityGrossMinorityInterest | 3.36M | 11.79M | 27.28M |
| StockholdersEquity | 3.36M | 11.79M | 27.28M |
| RetainedEarnings | -242.53M | -233.94M | -217.60M |
| AdditionalPaidInCapital | 245.89M | 245.73M | 244.88M |
| CapitalStock | 0.00 | 0.00 | 2.00K |
| CommonStock | 0.00 | 0.00 | 2.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 2.38M | 1.80M | 11.54M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 607.00K | 6.42M |
| DerivativeProductLiabilities | 0.00 | 44.00K | 5.80M |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 274.00K | 614.00K |
| LongTermCapitalLeaseObligation | 0.00 | 274.00K | 614.00K |
| LongTermProvisions | 289.00K | ||
| CurrentLiabilities | 2.38M | 1.19M | 5.12M |
| CurrentDebtAndCapitalLeaseObligation | 274.00K | 340.00K | 311.00K |
| CurrentCapitalLeaseObligation | 274.00K | 340.00K | 311.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 0.00 | 143.00K | 389.00K |
| PayablesAndAccruedExpenses | 2.10M | 709.00K | 4.42M |
| CurrentAccruedExpenses | 1.27M | 460.00K | 4.00M |
| Payables | 834.00K | 249.00K | 427.00K |
| OtherPayable | 62.00K | ||
| TotalTaxPayable | 22.00K | 152.00K | |
| AccountsPayable | 750.00K | 97.00K | 427.00K |
| TotalAssets | 5.74M | 13.59M | 38.83M |
| TotalNonCurrentAssets | 0.00 | 259.00K | 3.19M |
| NetPPE | 0.00 | 259.00K | 3.19M |
| AccumulatedDepreciation | 0.00 | -9.24M | -8.23M |
| GrossPPE | 0.00 | 9.50M | 11.43M |
| Leases | 0.00 | 4.96M | 6.08M |
| OtherProperties | 238.00K | ||
| MachineryFurnitureEquipment | 0.00 | 4.54M | 5.35M |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 5.74M | 13.33M | 35.63M |
| OtherCurrentAssets | 342.00K | 642.00K | 549.00K |
| CurrentDeferredAssets | 136.00K | 0.00 | |
| PrepaidAssets | 249.00K | 34.00K | 1.12M |
| Inventory | 0.00 | 72.00K | |
| OtherInventories | 72.00K | ||
| Receivables | 920.00K | 0.00 | 16.00K |
| OtherReceivables | 920.00K | 16.00K | |
| CashCashEquivalentsAndShortTermInvestments | 4.09M | 12.65M | 33.89M |
| CashAndCashEquivalents | 4.09M | 12.65M | 33.89M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| FreeCashFlow | -8.56M | -21.13M | -14.19M |
| RepurchaseOfCapitalStock | -186.00K | ||
| IssuanceOfCapitalStock | 98.00K | 0.00 | 33.01M |
| CapitalExpenditure | -97.00K | ||
| EndCashPosition | 4.09M | 12.65M | 33.89M |
| BeginningCashPosition | 12.65M | 33.89M | 17.35M |
| ChangesInCash | -8.56M | -21.24M | 16.55M |
| FinancingCashFlow | 0.00 | -111.00K | 30.73M |
| CashFlowFromContinuingFinancingActivities | 0.00 | -111.00K | 30.73M |
| NetOtherFinancingCharges | -98.00K | -111.00K | -2.51M |
| ProceedsFromStockOptionExercised | 0.00 | 234.00K | |
| NetCommonStockIssuance | 98.00K | 0.00 | 33.01M |
| CommonStockPayments | -186.00K | ||
| CommonStockIssuance | 98.00K | 0.00 | 33.01M |
| InvestingCashFlow | 0.00 | 0.00 | -97.00K |
| CashFlowFromContinuingInvestingActivities | 0.00 | -97.00K | |
| NetPPEPurchaseAndSale | 0.00 | -97.00K | |
| PurchaseOfPPE | 0.00 | -97.00K | |
| OperatingCashFlow | -8.56M | -21.13M | -14.09M |
| CashFlowFromContinuingOperatingActivities | -8.56M | -21.13M | -14.09M |
| ChangeInWorkingCapital | 15.00K | -2.97M | 2.58M |
| ChangeInOtherCurrentLiabilities | -265.00K | -79.00K | -89.00K |
| ChangeInPayablesAndAccruedExpense | 1.25M | -3.96M | 3.26M |
| ChangeInPrepaidAssets | -51.00K | 1.06M | -593.00K |
| ChangeInReceivables | -920.00K | 0.00 | |
| OtherNonCashItems | -284.00K | 7.00K | 80.00K |
| StockBasedCompensation | 159.00K | 953.00K | 2.72M |
| AssetImpairmentCharge | 0.00 | 1.94M | 0.00 |
| DepreciationAmortizationDepletion | 122.00K | 1.05M | 1.09M |
| DepreciationAndAmortization | 122.00K | 1.05M | 1.09M |
| OperatingGainsLosses | 56.00K | -5.76M | -3.49M |
| GainLossOnInvestmentSecurities | -5.76M | -3.49M | |
| GainLossOnSaleOfPPE | 56.00K | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | -8.63M | -16.34M | -17.07M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AMPE
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|